Comparing Brexafemme vs Diflucan
| Brexafemme (ibrexafungerp) | Diflucan (fluconazole) |
|
|---|
| Brexafemme (ibrexafungerp) | Diflucan (fluconazole) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Vaginal Yeast Infection. Brexafemme may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Candida Urinary Tract Infection, Candidemia, Blastomycosis, Bone Marrow Transplantation, Chronic Mucocutaneous Candidiasis, Coccidioidomycosis, Coccidioidomycosis - Meningitis... View more |
Related suggestions Vaginal Yeast Infection
|
|||||||
| More about Brexafemme (ibrexafungerp) | More about Diflucan (fluconazole) | ||||||||
| Ratings & Reviews | |||||||||
|
Brexafemme has an average rating of 4.5 out of 10 from a total of 2 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 50% reported a negative effect. |
Diflucan has an average rating of 5.9 out of 10 from a total of 144 ratings on Drugs.com. 51% of reviewers reported a positive effect, while 36% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Brexafemme side effects |
View all Diflucan side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Brexafemme prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
|
||||||||
| Brand Names | |||||||||
|
N/A |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
20 hours |
50 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
Single 150 Mg Tablet Use For Vaginal Candidiasis
Category D
Positive evidence of risk
All Indications (excluding Single 150 Mg Tablet Use For Vaginal Candidiasis) See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 79 drugs are known to interact with Brexafemme:
|
A total of 572 drugs are known to interact with Diflucan:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
June 01, 2021 |
January 29, 1990 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
|
|||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.